| Enriched cancer pathway | Genes under regulation | P value |
|---|
| B cell receptor signaling pathway |
6 genes: VAV3, KRAS, RAF1, SOS1, SOS2, BCL10
|
0.007054 |
| Neurotrophin signaling pathway |
8 genes: RPS6KA6, KRAS, MAP3K5, RAF1, RPS6KA3, SOS1, SOS2, RIPK2
|
0.008388 |
| Peroxisome |
6 genes: ACOX1, PEX13, CROT, FAR2, SCP2, FAR1
|
0.009033 |
| T cell receptor signaling pathway |
7 genes: VAV3, KRAS, RAF1, SOS1, SOS2, TEC, BCL10
|
0.01148 |
| Endocytosis |
10 genes: PDCD6IP, FGFR4, VPS36, EPN3, RAB5A, TFRC, PARD6G, RAB11A, USP8, CHMP4C
|
0.01766 |
| Dorso.ventral axis formation |
3 genes: KRAS, SOS1, SOS2
|
0.01834 |
| Regulation of actin cytoskeleton |
10 genes: VAV3, FGFR4, ARHGEF12, KRAS, SSH3, RAF1, SOS1, SOS2, EZR, SCIN
|
0.02443 |
| Fc epsilon RI signaling pathway |
5 genes: VAV3, KRAS, RAF1, SOS1, SOS2
|
0.03354 |
| Glycerophospholipid metabolism |
5 genes: LYPLA1, DGKA, DGKH, GPD2, ETNK1
|
0.03513 |
| Ras signaling pathway |
10 genes: FGFR4, SOS1, SOS2, KRAS, NF1, FOXO4, RAF1, REL, RALBP1, RAB5A
|
0.04321 |
| Progesterone.mediated oocyte maturation |
5 genes: SPDYA, RPS6KA6, KRAS, RAF1, RPS6KA3
|
0.04762 |